Big Move For Aptose Biosciences Inc.
Thu, Dec 16, 2021 at 05:30 PM
Aptose Biosciences Inc. (APTO:NASDAQ) rocketted at $1.47, a gain of 23.5%. On Wed, Dec 15, 2021, APTO:NASDAQ hit a New 2-Week Intraday Low of $1.09. The stock got featured on our News Catalysts scanner on Wed, Dec 15, 2021 at 08:24 AM in the 'INSIDER' category. From Wed, Dec 01, 2021, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Nov 17, 2021 at $2.78 with a volume of 1M+.
About Aptose Biosciences Inc. (APTO:NASDAQ)
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology.
Top 10 Gainers:
- ADGI (ADGI:NASDAQ), 123.31%
- XFIN (XFIN:NASDAQ), 100%
- Kaixin Auto Holdings (KXIN:NASDAQ), 36.29%
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 23.7%
- Aptose Biosciences Inc. (APTO:NASDAQ), 23.53%
- CALT (CALT:NASDAQ), 22.29%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 21.06%
- Zai Lab Limited (ZLAB:NASDAQ), 20.69%
- BSN (BSN:NYSE), 19.06%
- X4 Pharmaceuticals, Inc. (XFOR:NASDAQ), 17.33%